This study asks whether 3D-printed, PCL-reinforced bi-phasic cartilaginous templates can regenerate critically sized osteochondral defects by spatially directing endochondral ossification in the deep zone and stable hyaline cartilage formation at the surface. Construct design was validated first in vitro, then subcutaneously in nude mice, and finally in a 6×6 mm caprine medial femoral condyle defect model at 6 months.
Full-thickness osteochondral defects remain one of the hardest problems in joint preservation surgery because cartilage and bone have opposing requirements: the chondral surface must resist vascularisation and ossification, while the subchondral bone must actively recruit vasculature to heal. Commercial acellular scaffolds address geometry but not this biological conflict.
This paper demonstrates a proof-of-concept solution: programme two cell populations into a single implant before it goes in, so the deep zone drives endochondral ossification and the surface zone resists it. The FPSC-chondrocyte co-culture in the chondral layer is not decorative — it actively suppresses mineralisation and vessel ingrowth, as confirmed by the nude mouse data.
For a trainee thinking about cartilage restoration: the choice of reinforcing polymer matters enormously. PLGA-based networks degrade too fast under physiologic culture conditions and release acid that kills cells. PCL, despite its slow degradation, is the current best option for maintaining construct integrity through the chondrogenic priming period.
The caprine data show meaningful gains in matrix quality and cell morphology over a leading commercial scaffold, but the 1-in-6 collapse rate is the number to keep in mind. Biological performance means nothing if the implant fails mechanically at the host-graft interface.
This study asks whether 3D-printed, PCL-reinforced bi-phasic cartilaginous templates can regenerate critically sized osteochondral defects by spatially directing endochondral ossification in the deep zone and stable hyaline cartilage formation at the surface. Construct design was validated first in vitro, then subcutaneously in nude mice, and finally in a 6×6 mm caprine medial femoral condyle defect model at 6 months.
Full-thickness osteochondral defects remain one of the hardest problems in joint preservation surgery because cartilage and bone have opposing requirements: the chondral surface must resist vascularisation and ossification, while the subchondral bone must actively recruit vasculature to heal. Commercial acellular scaffolds address geometry but not this biological conflict.
This paper demonstrates a proof-of-concept solution: programme two cell populations into a single implant before it goes in, so the deep zone drives endochondral ossification and the surface zone resists it. The FPSC-chondrocyte co-culture in the chondral layer is not decorative — it actively suppresses mineralisation and vessel ingrowth, as confirmed by the nude mouse data.
For a trainee thinking about cartilage restoration: the choice of reinforcing polymer matters enormously. PLGA-based networks degrade too fast under physiologic culture conditions and release acid that kills cells. PCL, despite its slow degradation, is the current best option for maintaining construct integrity through the chondrogenic priming period.
The caprine data show meaningful gains in matrix quality and cell morphology over a leading commercial scaffold, but the 1-in-6 collapse rate is the number to keep in mind. Biological performance means nothing if the implant fails mechanically at the host-graft interface.